SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-21-000369
Filing Date
2021-02-17
Accepted
2021-02-17 06:02:33
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B5 a2242927z424b5.htm 424B5 1230647
2 G533806.JPG g533806.jpg GRAPHIC 13904
3 G36258.JPG g36258.jpg GRAPHIC 130091
4 G642712.JPG g642712.jpg GRAPHIC 116394
5 G600888.JPG g600888.jpg GRAPHIC 30792
6 G89689.JPG g89689.jpg GRAPHIC 96250
7 G367988.JPG g367988.jpg GRAPHIC 37592
8 G207533.JPG g207533.jpg GRAPHIC 18499
9 G106234.JPG g106234.jpg GRAPHIC 29630
10 G334429.JPG g334429.jpg GRAPHIC 41375
11 G175996.JPG g175996.jpg GRAPHIC 30849
12 G129068.JPG g129068.jpg GRAPHIC 18202
13 G268424.JPG g268424.jpg GRAPHIC 189317
14 G207942.JPG g207942.jpg GRAPHIC 22377
  Complete submission text file 0001047469-21-000369.txt   2301192
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-234034 | Film No.: 21642529
SIC: 2834 Pharmaceutical Preparations